Published in Cancer Weekly, December 2nd, 2003
Higher-risk forms of cancer, such as locally advanced breast cancer (LABC), are often treated with chemotherapy prior to surgery in order to enhance the probability of surgical success. Predicting the effectiveness of this pre-surgery chemotherapy can spare patients exposure to ineffective treatment and save money in the long run.
Recently, a team of University of Washington researchers conducted a study to determine if 18F-FDG and 15O-water PET (positron...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly